Clinical Trials Directory

Trials / Completed

CompletedNCT01941901

Calcium Electroporation for Treatment of Cutaneous Metastases

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
7 (actual)
Sponsor
Herlev Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effect of calcium electroporation on cutaneous metastases, and compare calcium electroporation with standard treatment: electrochemotherapy.

Detailed description

Double-blinded phase II clinical study. We will compare the effect of calcium electroporation for the treatment of cutaneous metastases with standard treatment: electrochemotherapy with intratumoral injection of bleomycin. Separate randomisation will be performed and the lesions will be treated with either intratumoral injection of calcium or bleomycin. It is a once only treatment and the patients will be followed up for 6 months. It is a non-inferiority study and we accept a difference in response on 15%.

Conditions

Interventions

TypeNameDescription
DRUGCalcium electroporationIntratumoral injection, once only treatment.
DRUGElectrochemotherapy with bleomycinIntratumoral injection, once only treatment

Timeline

Start date
2013-09-01
Primary completion
2016-09-01
Completion
2017-01-23
First posted
2013-09-13
Last updated
2019-11-05

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01941901. Inclusion in this directory is not an endorsement.